Targeting several tumor/metastasis suppressor genes, including PDCD4, PTEN, and TIMP3, miR-21 contributes to invasion and metastasis, indicating its potential as an anti-metastasis therapeutic. This evidence concerns the gene PTEN and neoplasm.